$66.17 -0.84 (-1.25%) AbbVie Inc - New York Stock Exchange, Inc.

Aug. 23, 2016 | 04:00 PM
Last Trade: 66.17
Trade Time: Aug 23 04:00 PM Eastern Daylight Time
Change: -0.84 (-1.25%)
Prev Close: 67.01
Open: 67.26
Bid: 66.12
Ask: 66.30
  1. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 12:13PM EST
  2. Trending on Dividend.com: Technology Stocks Gain Visibility as Earnings Season Is Underway

    Dividend.com | Jul. 29, 2016 | 12:00PM EST
  3. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 10:46AM EST
  4. Exxon, Chevron, Merck Earnings, Q2 GDP Data On Tap Friday

    Investors Business Daily | Jul. 28, 2016 | 17:21PM EST
  5. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 08:00AM EST
  6. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 13:57PM EST
  7. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  8. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  9. IPO Indexes Weak, But A Few Leaders Outperform

    IBD | Feb. 10, 2016 | 16:42PM EST
  10. The Generic Drug Battle

    Benzinga | Feb. 10, 2016 | 09:13AM EST
  11. Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

    Benzinga | Feb. 8, 2016 | 15:27PM EST
  12. Benzinga's Top Initiations

    Benzinga | Feb. 5, 2016 | 09:32AM EST
  13. Is Big Pharma Hinting At A SMID-Cap Biotech Rally?

    Benzinga | Feb. 3, 2016 | 13:16PM EST
  14. Earnings Recap For January 29

    Benzinga | Jan. 29, 2016 | 17:36PM EST
  15. Biogen Drug 'Increasingly Vulnerable,' Analyst Warns After Speaking With MS Expert

    Benzinga | Jan. 29, 2016 | 09:29AM EST
Trading Center